GB8903804D0 - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
GB8903804D0
GB8903804D0 GB898903804A GB8903804A GB8903804D0 GB 8903804 D0 GB8903804 D0 GB 8903804D0 GB 898903804 A GB898903804 A GB 898903804A GB 8903804 A GB8903804 A GB 8903804A GB 8903804 D0 GB8903804 D0 GB 8903804D0
Authority
GB
United Kingdom
Prior art keywords
relating
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898903804A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10651981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB8903804(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to GB898903804A priority Critical patent/GB8903804D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8903804D0 publication Critical patent/GB8903804D0/en
Priority to GB9003616A priority patent/GB2228198B/en
Priority to CH504/90A priority patent/CH680650A5/de
Priority to JP2038168A priority patent/JPH0611703B2/ja
Priority to DE4005190A priority patent/DE4005190A1/de
Priority to FR9002086A priority patent/FR2643262B1/fr
Priority to BE9000181A priority patent/BE1005236A3/fr
Priority to IT47650A priority patent/IT1240765B/it
Priority to US08/163,193 priority patent/US5639724A/en
Priority to US08/471,302 priority patent/US5652212A/en
Priority to US08/471,301 priority patent/US5759997A/en
Priority to HK149595A priority patent/HK149595A/xx
Priority to SA95160491A priority patent/SA95160491B1/ar
Priority to CY188696A priority patent/CY1886A/en
Priority to US09/047,056 priority patent/US5977066A/en
Priority to US09/552,634 priority patent/US6306825B1/en
Priority to US09/931,680 priority patent/US6468968B2/en
Priority to US10/234,273 priority patent/US20030060402A1/en
Priority to US10/790,543 priority patent/US7081445B2/en
Priority to US11/453,504 priority patent/US7511014B2/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GB898903804A 1984-07-24 1989-02-20 Improvements in or relating to organic compounds Pending GB8903804D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB898903804A GB8903804D0 (en) 1989-02-20 1989-02-20 Improvements in or relating to organic compounds
GB9003616A GB2228198B (en) 1989-02-20 1990-02-16 Novel cyclosporin galenic forms
CH504/90A CH680650A5 (cg-RX-API-DMAC7.html) 1989-02-20 1990-02-16
BE9000181A BE1005236A3 (fr) 1989-02-20 1990-02-19 Compositions pharmaceutiques a base de cyclosporines.
FR9002086A FR2643262B1 (fr) 1989-02-20 1990-02-19 Compositions pharmaceutiques a base de cyclosporines
JP2038168A JPH0611703B2 (ja) 1989-02-20 1990-02-19 新規シクロスポリン製剤
DE4005190A DE4005190A1 (de) 1989-02-20 1990-02-19 Neue cyclosporinhaltige galenische formen
IT47650A IT1240765B (it) 1989-02-20 1990-02-20 Composizioni farmaceutiche a base di ciclosporine.
US08/163,193 US5639724A (en) 1984-07-24 1993-12-06 Cyclosporin galenic forms
US08/471,302 US5652212A (en) 1984-07-24 1995-06-06 Cyclosporin galenic forms
US08/471,301 US5759997A (en) 1984-07-24 1995-06-06 Cyclosporin galenic forms
HK149595A HK149595A (en) 1989-02-20 1995-09-21 Novel cyclosporin galenic forms
SA95160491A SA95160491B1 (ar) 1989-02-20 1995-12-31 تكوينات forms جالينية galenic جديدة من سيكلوسبورين cyclosporin
CY188696A CY1886A (en) 1989-02-20 1996-04-05 Novel cyclosporin galenic forms
US09/047,056 US5977066A (en) 1984-07-24 1998-03-24 Cyclosporin galenic forms
US09/552,634 US6306825B1 (en) 1984-07-24 2000-04-19 Cyclosporin galenic forms
US09/931,680 US6468968B2 (en) 1984-07-24 2001-08-16 Cyclosporin galenic forms
US10/234,273 US20030060402A1 (en) 1984-07-24 2002-09-04 Novel cyclosporin galenic forms
US10/790,543 US7081445B2 (en) 1989-02-20 2004-03-01 Cyclosporin galenic forms
US11/453,504 US7511014B2 (en) 1989-02-20 2006-06-15 Cyclosporin galenic forms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898903804A GB8903804D0 (en) 1989-02-20 1989-02-20 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
GB8903804D0 true GB8903804D0 (en) 1989-04-05

Family

ID=10651981

Family Applications (2)

Application Number Title Priority Date Filing Date
GB898903804A Pending GB8903804D0 (en) 1984-07-24 1989-02-20 Improvements in or relating to organic compounds
GB9003616A Expired - Lifetime GB2228198B (en) 1989-02-20 1990-02-16 Novel cyclosporin galenic forms

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9003616A Expired - Lifetime GB2228198B (en) 1989-02-20 1990-02-16 Novel cyclosporin galenic forms

Country Status (9)

Country Link
JP (1) JPH0611703B2 (cg-RX-API-DMAC7.html)
BE (1) BE1005236A3 (cg-RX-API-DMAC7.html)
CH (1) CH680650A5 (cg-RX-API-DMAC7.html)
CY (1) CY1886A (cg-RX-API-DMAC7.html)
DE (1) DE4005190A1 (cg-RX-API-DMAC7.html)
FR (1) FR2643262B1 (cg-RX-API-DMAC7.html)
GB (2) GB8903804D0 (cg-RX-API-DMAC7.html)
HK (1) HK149595A (cg-RX-API-DMAC7.html)
IT (1) IT1240765B (cg-RX-API-DMAC7.html)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
IL102236A0 (en) * 1991-06-27 1993-01-14 Ltt Inst Co Ltd Topical preparations containing cyclosporin
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
AU688920B2 (en) * 1991-06-27 1998-03-19 Novartis Ag Transesterified corn oil products
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5759566A (en) * 1992-07-28 1998-06-02 Poli Industria Chimica Spa Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
EP1142568A1 (en) * 1992-09-25 2001-10-10 Novartis AG Pharmaceutical compositions containing cyclosporins
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE4412201A1 (de) * 1993-04-20 1994-11-10 Rentschler Arzneimittel Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
CZ291237B6 (cs) † 1993-04-20 2003-01-15 Novartis Ag Farmaceutický přípravek pro orální podání obsahující cyklosporin A
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
WO1995022343A1 (en) * 1994-02-17 1995-08-24 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5474979A (en) * 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
DK0756489T3 (da) * 1994-06-01 1999-12-06 Yuhan Corp Cyclosporinholdigt præparat og fremgangsmåde til fremstillingen af dette
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6475519B1 (en) 1997-01-30 2002-11-05 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
EP0969856B1 (en) * 1997-03-12 2005-01-05 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
JP2001515491A (ja) * 1997-03-12 2001-09-18 アボツト・ラボラトリーズ 親油性化合物の投与のための親油性二成分系
US6531139B1 (en) * 1997-07-29 2003-03-11 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
PT989851E (pt) 1997-07-29 2002-12-31 Upjohn Co Formulacao auto-emulsionante para compostos lipofilicos acidicos
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
DE19859910C2 (de) * 1998-12-23 2001-03-22 Ratiopharm Gmbh Orales Arzneimittel
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB9912476D0 (en) 1999-05-28 1999-07-28 Novartis Ag Organic compounds
AU2127400A (en) * 1999-11-02 2001-05-14 Cipla Limited A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
GB2362573A (en) * 2000-05-25 2001-11-28 Cipla Ltd Cyclosporin formulation
DE60018715T2 (de) * 2000-05-04 2006-04-27 Panacea Biotec Ltd. Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil
DE10030378A1 (de) * 2000-06-21 2002-03-14 Audit Inst For Medical Service Neue pharmazeutische Zusammensetzung zur topischen Anwendung von wasserunlöslichen und/oder schwer wasserlöslichen Wirkstoffen
CN1274294C (zh) 2001-10-19 2006-09-13 伊索泰克尼卡股份有限公司 环孢菌素类似物微乳液预浓缩物
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
JP4381037B2 (ja) 2003-06-04 2009-12-09 花王株式会社 油脂組成物
MX2007011250A (es) * 2005-03-21 2007-11-14 Ivax Pharmaceuticals Sro Inhibidor de la cristalizacion y su uso en capsulas de gelatina.
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
AU2006236564B2 (en) 2005-04-15 2011-02-17 Besins Healthcare Luxembourg S.A.R.L. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
FR2914188B1 (fr) * 2007-03-28 2012-06-22 Trophos Nouvelle composition a base d'oxime de cholest-4-en-3-one
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JP6448553B2 (ja) 2014-01-16 2019-01-09 マルホ株式会社 経皮投与用外用剤
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease
CN113784722B (zh) 2019-04-11 2024-10-22 R·P·舍勒科技有限责任公司 用于有不良渗透性的蛋白质、肽和小分子的口服递送的制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
PH19156A (en) * 1982-02-01 1986-01-15 Sandoz Ltd Dihydrocyclosporin d in the treatment of multiple sclerosis

Also Published As

Publication number Publication date
FR2643262B1 (fr) 1993-06-11
JPH0611703B2 (ja) 1994-02-16
IT9047650A0 (it) 1990-02-20
CH680650A5 (cg-RX-API-DMAC7.html) 1992-10-15
JPH02255623A (ja) 1990-10-16
DE4005190A1 (de) 1990-08-23
GB2228198A (en) 1990-08-22
IT9047650A1 (it) 1990-08-21
IT1240765B (it) 1993-12-17
GB2228198B (en) 1992-12-16
FR2643262A1 (fr) 1990-08-24
GB9003616D0 (en) 1990-04-11
BE1005236A3 (fr) 1993-06-08
HK149595A (en) 1995-09-29
CY1886A (en) 1996-04-05

Similar Documents

Publication Publication Date Title
GB8903804D0 (en) Improvements in or relating to organic compounds
AP9000217A0 (en) Improvements in or relating to organic compounds
GB8901517D0 (en) Improvements in or relating to organic compounds
AP9000207A0 (en) Improvements in or relating to organic compounds
GB8905716D0 (en) Improvements in or relating to organic compounds
GB8903146D0 (en) Improvements in or relating to organic compounds
GB8902154D0 (en) Improvements in or relating to organic compounds
GB8902303D0 (en) Improvements in or relating to organic compounds
GB8902304D0 (en) Improvements in or relating to organic compounds
GB8902305D0 (en) Improvements in or relating to organic compounds
GB8902656D0 (en) Improvements in or relating to organic compounds
GB8902897D0 (en) Improvements in or relating to organic compounds
GB8902898D0 (en) Improvements in or relating to organic compounds
GB8900455D0 (en) Improvements in or relating to organic compounds
GB8902899D0 (en) Improvements in or relating to organic compounds
GB8902900D0 (en) Improvements in or relating to organic compounds
GB8902901D0 (en) Improvements in or relating to organic compounds
GB8902902D0 (en) Improvements in or relating to organic compounds
GB8902903D0 (en) Improvements in or relating to organic compounds
GB8905715D0 (en) Improvements in or relating to organic compounds
GB8903147D0 (en) Improvements in or relating to organic compounds
GB8906631D0 (en) Improvements in or relating to organic compounds
GB8900246D0 (en) Improvements in or relating to organic compounds
GB8904645D0 (en) Improvements in or relating to organic compounds
GB8906633D0 (en) Improvements in or relating to organic compounds